HealthcareServices

Global Medical Health Screening Market Forecast 2026–2035: Long-Term Growth Insights

February 26, 2026February 27, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the medical health screening market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Medical Health Screening Market?

The medical health screening market size has experienced robust expansion in recent years. It is projected to increase from $19.74 billion in 2025 to $21.06 billion in 2026, at a compound annual growth rate (CAGR) of 6.7%. The historical growth can be attributed to heightened awareness of preventive healthcare, the expansion of diagnostic laboratory networks, a rising prevalence of chronic diseases, improved access to routine testing services, and the growth of employer-sponsored health programs.

The medical health screening market is projected to experience substantial expansion in the coming years. It is anticipated to reach $26.97 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.4%. This growth during the forecast period is attributable to several factors, including the increasing embrace of personalized medicine approaches, the rising integration of digital health platforms, the broadening of population-level screening initiatives, the growing demand for home-based testing services, and a heightened emphasis on early cancer detection. Key trends anticipated for this period encompass a greater adoption of preventive health screening programs, an increasing utilization of multi-parameter diagnostic panels, an expanding need for early disease detection services, the widening scope of corporate and occupational health screening, and a stronger focus on personalized screening protocols.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25824&type=smp

Which Drivers Are Supporting The Rise Of The Medical Health Screening Market?

The increasing incidence of chronic illnesses is anticipated to fuel the expansion of the medical health screening market in the future. Chronic conditions are defined as enduring health issues, including diabetes, heart disease, and asthma, which typically last for a minimum of a year, necessitating ongoing medical attention or hindering everyday activities. The occurrence of chronic ailments is increasing primarily because of inactive lifestyles, given that extended periods of inactivity diminish general bodily health and heighten susceptibility to prolonged medical conditions. Medical health screening holds significant importance for chronic diseases by facilitating the prompt detection of risk factors and signs, thus allowing for swift intervention and treatment to avert complications, enhance life quality, and mitigate the overall impact of these persistent conditions. For example, as reported in April 2025 by the International Diabetes Federation, a non-profit organization based in Belgium, a current total of 589 million adults aged 20–79 globally suffer from diabetes, with projections indicating an increase to 853 million by 2050. Consequently, the growing frequency of chronic diseases is propelling the expansion of the medical health screening market.

What Segments Are Identified Within The Structure Of The Medical Health Screening Market?

The medical health screening market covered in this report is segmented –

1) By Test Type: Routine Tests, Non-Routine Tests, Cancer Screening Tests, Specialty Tests, Other Test Types

2) By Sample Type: Blood, Urine, Saliva, Other Sample Types

3) By End User: Hospitals Or Clinics, Diagnostic Laboratories, Workplaces, Research Institutes, Other End Users

Subsegments:

1) By Routine Tests: Blood Pressure Monitoring, Blood Glucose Testing, Lipid Profile, Complete Blood Count (CBC), Urinalysis

2) By Non-Routine Tests: Genetic Testing, Hormonal Testing, Allergy Testing, Infectious Disease Testing

3) By Cancer Screening Tests: Mammography, Pap Smear Test, Colonoscopy, Prostate-Specific Antigen (PSA) Test, Low-Dose CT Scan For Lung Cancer

4) By Specialty Tests: Cardiovascular Screening, Neurological Screening, Pulmonary Function Tests, Bone Density Test

5) By Other Test Types: Wellness Tests, Executive Health Checkups, Prenatal Screening, Occupational Health Screening

Which Innovation Trends Are Advancing Developments Within The Medical Health Screening Market?

Major companies operating in the medical health screening market are prioritizing the introduction of innovative solutions, such as artificial intelligence-powered radiology informatics and cancer screening, aimed at improving early detection, enhancing diagnostic accuracy, and optimizing clinical workflows. AI-powered radiology informatics and cancer screening refers to the application of artificial intelligence technologies to analyze medical imaging data, enabling the identification of potential signs of cancer or other abnormalities with greater speed and precision. For instance, in February 2025, DeepHealth, a US-based health informatics company, unveiled a new suite of AI-powered radiology informatics and cancer screening solutions, driven by their cloud-native operating system, DeepHealth OS. This offering includes the Diagnostic Suite, a unified AI-driven diagnostic workspace, and advanced AI tools for lung, prostate, and brain health screening. These innovations collectively seek to boost clinical accuracy, streamline operational procedures, and enhance efficiency across diverse healthcare settings.

Which Major Industry Participants Are Leading The Medical Health Screening Market Growth?

Major companies operating in the medical health screening market are Abbott Laboratories, Siemens Healthineers AG, Labcorp Holdings Inc, Quest Diagnostics Incorporated, Eurofins Scientific SE, QuidelOrtho Corporation, Exact Sciences Corporation, Unilabs AB, LifeLabs LP, ARUP Laboratories, BioReference Health LLC, Guardant Health Inc, DDRC Agilus Diagnostics Limited, Clinical Reference Laboratory Inc, Freenome Holdings Inc, Genova Diagnostics Inc, Cerba Healthcare SAS, DELFI Diagnostics Inc, Truvian Sciences Inc, ACM Medical Laboratory Inc, LabPlus, Sonic Healthcare Limited

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/medical-health-screening-global-market-report

Which Region Currently Holds The Largest Share Of The Medical Health Screening Market?

North America was the largest region in the medical health screening market in 2025. The regions covered in the medical health screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Medical Health Screening Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25824&type=smp

Browse Through More Reports Similar to the Global Medical Health Screening Market 2026, By The Business Research Company

Population Screening Market Report 2026

https://www.thebusinessresearchcompany.com/report/population-screening-global-market-report

Blood Screening Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-screening-global-market-report

Cellular Health Screening Market Report 2026

https://www.thebusinessresearchcompany.com/report/cellular-health-screening-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795